Back to search
Systemic Mastocytosis With an Associated Hematologic Neoplasm
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Systemic Mastocytosis With an Associated Hematologic Neoplasm trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Systemic Mastocytosis With an Associated Hematologic Neoplasm trials you may qualify forThis is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patient…
Systemic mastocytosis with an associated hematologic neoplasm (SM-AHN) is a challenging disease to treat. Targeted KIT inhibitors have been approved for this in…
The purpose of this expanded access program (EAP) protocol is to provide investigational bezuclastinib to patients with a diagnosis of nonadvanced systemic mast…
This is an open-label, single arm, Phase 2 study evaluating the efficacy and safety of avapritinib (BLU-285) in patients with advanced systemic mastocytosis (Ad…
The purpose of this registration is to list Managed Access Programs (MAPs) related to PKC4, Midostaurin.